THERASPHERE

TheraSphere is a targeted radioembolization therapy made of glass microspheres containing radioactive Yttrium-90 (Y-90). Designed for control to achieve durable patient outcomes, TheraSphere preserves quality of life and provides reproducible results for treating and referring physicians. As the only FDA-approved Y-90 therapy for HCC, it is a cost-effective procedure backed by committed support from the industry leader, Boston Scientific... TheraSphere is a registered trademark of Theragenics Corporation used under license by Boston Scientific Medical Device Limited, a wholly owned indirect subsidiary of Boston Scientific Corporation... Discover how TheraSphere Y-90 offers targeted radioembolization therapy for hepatocellular carcinoma (HCC) treatment in interventional oncology.

Primary location: Marlborough United States